1H-Nuclear Magnetic Resonance Spectroscopy of Glioblastoma Cancer Stem Cells

Stem Cells and Development

Volumn 20, Issue 12, 2011, Pages 2189-2195

  Ramm, Paul ^a   Bettscheider, Marc ^a   Beier, Dagmar ^a,b   Kalbitzer, Hans Robert ^a   Kremer, Werner ^a   Bogdahn, Ulrich ^a   Hau, Peter ^a   Aigner, Ludwig ^a,c   Beier, Christoph P ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; LIPID; PROTON;

ARTICLE; CANCER STEM CELL; CELL DEATH; CELL LINE; CLONOGENESIS; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PILOT STUDY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; CLUSTER ANALYSIS; LIPID METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CLUSTER ANALYSIS; GLIOBLASTOMA; HUMANS; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASTIC STEM CELLS; PRINCIPAL COMPONENT ANALYSIS; PROTONS;

EID: 82455171737     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0567     Document Type: Article

References (39)

1. Beier CP, C Schmid, T Gorlia, C Kleinletzenberger, D Beier, O Grauer, A Steinbrecher, B Hirschmann, A Brawanski, C Dietmaier, T Jauch-Worley, T Pietsch, M Proescholdt, P Rummele, A Muigg, G Stockhammer, M Hegi, U Bogdahn and P Hau2009). RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma-a phase II study. BMC Cancer 9:308.
2. Stupp R, WP Mason, MJ van den Bent, M Weller, B Fisher, MJ Taphoorn, K Belanger, AA Brandes, C Marosi, U Bogdahn, J Curschmann, RC Janzer, SK Ludwin, T Gorlia, A Allgeier, D Lacombe, JG Cairncross, E Eisenhauer and RO Mirimanoff2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996.
3. Reya T, SJ Morrison, MF Clarke and IL Weissman2001). Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
4. Beier D, J Wischhusen, W Dietmaier, P Hau, M Proescholdt, A Brawanski, U Bogdahn and CP Beier2008). CD133 Expressio and cancer stem cells predict prognosis in highgrade oligodendroglial tumors. Brain Pathol 18:370-377.
5. Laks DR, M Masterman-Smith, K Visnyei, B Angenieux, NM Orozco, I Foran, WH Yong, HV Vinters, LM Liau, JA Lazareff, PS Mischel, TF Cloughesy, S Horvath and HI Kornblum2009). Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 27:980-987.
6. Pallini R, L Ricci-Vitiani, GL Banna, M Signore, D Lombardi, M Todaro, G Stassi, M Martini, G Maira, LM Larocca and R De Maria2008). Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14:8205-8212.
7. Couillard-Despres S, B Winner, S Schaubeck, R Aigner, M Vroemen, N Weidner, U Bogdahn, J Winkler, HG Kuhn and L Aigner2005). Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 21:1-14.
8. Rueger MA, H Backes, M Walberer, B Neumaier, R Ullrich, ML Simard, B Emig, GR Fink, M Hoehn, Graf R and M Schroeter2010). Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J Neurosci 30:6454-6460.
9. Marthiens V and C ffrench-Constant2009). Adherens junction domains are split by asymmetric division of embryonic neural stem cells. EMBO Rep 10:515-520.
10. Gotz M and WB Huttner. The cell biology of neurogenesis2005). Nat Rev Mol Cell Biol 6:777-788.
11. Shimizu H, T Kumabe, R Shirane and T Yoshimoto2000). Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21:659-665.
12. Moller-Hartmann W, S Herminghaus, T Krings, G Marquardt, H Lanfermann,U Pilatus and FE Zanella2002). Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381.
13. Beier D, P Hau, M Proescholdt, A Lohmeier, J Wischhusen, PJ Oefner, L Aigner, A Brawanski, U Bogdahn and CP Beier2007). CD133 + and CD133- Glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010-4015.
14. Beier D, S Rohrl, DR Pillai, S Schwarz, Kunz-LA Schughart, P Leukel, M Proescholdt, A Brawanski, U Bogdahn, Trampe- Kieslich A, B Giebel, J Wischhusen, G Reifenberger, P Hau and CP Beier2008). Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 68:5706-5715.
15. Hwang TL and AJ Shaka1995). Water suppression that works. excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Mag Res Series A 112:275-279.
16. Wishart DS, C Knox, AC Guo, R Eisner, N Young, B Gautam, DD Hau, N Psychogios, E Dong, S Bouatra, R Mandal, I Sinelnikov, J Xia, L Jia, JA Cruz, E Lim, CA Sobsey, S Shrivastava, P Huang, P Liu, L Fang, J Peng, R Fradette, D Cheng, D Tzur, M Clements, A Lewis, A De Souza, A Zuniga, M Dawe, Y Xiong, D Clive, R Greiner, A Nazyrova, R Shaykhutdinov, L Li, HJ Vogel and I Forsythe2009). HMDB: a knowledgebase for the human metabolome. Nucl. Acids Res 37:D603-D610.
17. Ulrich EL, H Akutsu, JF Doreleijers, Y Harano, YE Ioannidis, J Lin, M Livny, S Mading, D Maziuk, Z Miller, E Nakatani, CF Schulte, DE Tolmie, Kent Wenger R, H Yao and JL Markley2008). BioMagResBank Nucl Acids Res 36:D402-D408.
18. Jansen JFA, MJ Shamblott, PCMv Zijl, KK Lehtimäki, JWM Bulte, JD Gearhart and JM Hakumäki2006). Stem cell profiling by nuclear magnetic resonance spectroscopy. Mag Res Med 56:666-670.
19. Urenjak J, SR Williams, DG Gadian and M Noble1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989.
20. K Kotitschke, JC Tonn, R Goldbrunner, U Bogdahn and A Haase1995). 1H NMR investigations of tumor spheroids grown from a human glioma biopsy or from a human malignant glioma cell line. J Mag Res Series B 109:39-43.
21. Kotitschke K, H Jung, S Nekolla, A Haase, A Bauer and U Bogdahn1994). High-resolution one- and two-dimensional 1H MRS of human brain tumor and normal glial cells. NMR Biomed 7:111-120.
22. Rosi A, S Grande, AM Luciani, P Barone, V Mlynarik, V Viti and L Guidoni2004). 1H MRS studies of signals from mobile lipids and from lipid metabolites: comparison of the behavior in cultured tumor cells and in spheroids. NMR Biomed 17:76-91.
23. Hakumäki JM and RA Kauppinen2000). 1H NMR visible lipids in the life and death of cells. Trends Biochem Sci 25:357-362.
24. Quintero M, ME Cabanas and C Arus. (2007). A possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glioma cells with growth. Biochim Biophys Acta 1771:31-44.
25. Al-Saffar NMS, JC Titley, D Robertson, PA Clarke, LE Jackson, MO Leach and SM Ronen. (2002). Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br J Cancer 86:963-970.
26. Ferretti A, A Knijn, E Iorio, S Pulciani, M Giambenedetti, A Molinari, S Meschini, A Stringaro, A Calcabrini, I Freitas, R Strom, G Arancia and F Podo. (1999). Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. Biochim Biophys Acta 1438:329-348.
27. Rémy C, N Fouilhé, I Barba, E Sam-Lai, H Lahrech, MG Cucurella, M Izquierdo, A Moreno, A Ziegler, R Massarelli, M Décorps and C Aris. (1997). Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res 57:407-414.
28. Barba I, P Mann, ME Cabanas, C Arus and C Gasparovic. (2001). Mobile lipid production after confluence and pH stress in perfused C6 cells. NMR Biomed 14:33-40.
29. Delikatny EJ, CM Lander, TM Jeitner, R Hancock and CE Mountford. (1996). Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int J Cancer 65:238-245.
30. RammP, S Couillard-Despres, S Plotz, FJ Rivera,MKrampert, B Lehner,WKremer, U Bogdahn, HR Kalbitzer and L Aigner. (2009). A nuclear magnetic resonance biomarker for neural progenitor cells: is it all neurogenesis? Stem Cells 27:420-423.
31. Behar KL and Ogino T. (1991). Assignment of resonance in the 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy. Mag Res Med 17:285-303.
32. Behar KL and T Ogino. (1993). Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain. Mag Res Med 30:38-44.
33. Behar KL, DL Rothman, DD Spencer and OA Petroff. (1994). Analysis of macromolecule resonances in 1H NMR spectra of human brain. Mag Res Med 32:294-302.
34. Kauppinen RA, T Niskanen, J Hakumäki and SR Williams. (1993). Quantitative analysis of 1H NMR detected proteins in the rat cerebral cortex in vivo and in vitro. NMR Biomed 6:242-247.
35. Kauppinen RA, T Nissinen, AM Kärkkäinen, TR Pirttilä, J Palvimo, H Kokko and SR Williams. (1992). Detection of thymosin beta 4 in situ in a guinea pig cerebral cortex preparation using 1H NMR spectroscopy.J Biol Chem 267:9905-9910.
36. Manganas LN, X Zhang, Y Li, RD Hazel, SD Smith, ME Wagshul, F Henn, H Benveniste, PM Djuric, G Enikolopov and M Maletic-Savatic. (2007). Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 318:980-985.
37. Wright A, G Fellows, J Griffiths, M Wilson, B Bell and F Howe. (2010). Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Mol Cancer 9:66.
38. Duarte IF, J Marques, AF Ladeirinha, Rocha C, Lamego I, R Calheiros, Silva TM, MPM Marques, JB Melo, IM Carreira and AM Gil. (2009). Analytical approaches toward successful human cell metabolome studies by NMR spectroscopy. Analyt Chem 81:5023-5032.
39. Wan F, S Zhang, R Xie, B Gao, B Campos, C Herold-Mende and T Lei. (2010). The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cells research. Brain Pathol 20:877-889.